Valuation: Elekta AB (publ)

Market Cap 19.46B 2.01B 1.73B 1.64B 1.49B 2.79B 192B 2.8B 7.48B 97.64B 7.54B 7.38B 309B P/E 2027 *
12.4x
P/E 2028 * 11.4x
Enterprise Value 22.86B 2.36B 2.03B 1.93B 1.74B 3.27B 225B 3.29B 8.79B 115B 8.86B 8.67B 362B EV / Sales 2027 *
1.32x
EV / Sales 2028 * 1.23x
Free-Float
94.03%
Yield 2027 *
5%
Yield 2028 * 5.61%
Manager TitleAgeSince
Chief Executive Officer - 2025-08-31
Director of Finance/CFO - 2026-02-28
Investor Relations Contact - 2023-11-30
Director TitleAgeSince
Director/Board Member 69 2010-06-29
Director/Board Member 70 2011-09-14
Chairman 74 2013-09-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 2.01B
+1.10%-0.65%+27.19%+19.36% 225B
-0.19%-3.62%+5.31%-20.72% 141B
+2.41%+0.67%-17.91%+21.95% 130B
-0.28%-10.08%-58.15%-19.21% 62.29B
+2.37%+1.37%-18.11%-13.58% 49.39B
-2.77%-6.15%+8.77%+15.31% 48.63B
+2.66%-2.61%+19.22%+29.53% 41.42B
+1.67%-0.25%+38.24%+52.80% 40.12B
-0.60%-4.41%-19.20%+49.15% 31.23B
Average +0.72%-3.23%-1.63%+14.96% 85.52B
Weighted average by Cap. +0.71%-2.40%+2.84%+10.48%

Financials

2027 *2028 *
Net sales 17.34B 1.79B 1.54B 1.46B 1.32B 2.48B 171B 2.49B 6.67B 86.97B 6.72B 6.57B 275B 18.1B 1.87B 1.61B 1.52B 1.38B 2.59B 178B 2.6B 6.96B 90.78B 7.01B 6.86B 287B
Net income 1.51B 156M 134M 127M 115M 216M 14.91B 218M 581M 7.59B 586M 573M 23.97B 1.64B 169M 146M 138M 125M 235M 16.16B 236M 630M 8.22B 635M 621M 25.98B
Net Debt 3.4B 351M 302M 286M 259M 487M 33.53B 489M 1.31B 17.06B 1.32B 1.29B 53.9B 2.88B 297M 256M 242M 220M 412M 28.38B 414M 1.11B 14.44B 1.12B 1.09B 45.63B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!